HIV integrase inhibitors

Details for Australian Patent Application No. 2007313293 (hide)

Owner Merck & Co., Inc.

Inventors Fisher, Thorsten E.; Wai, John S.; Payne, Linda S.; Isaacs, Richard C.A.

Agent Spruson & Ferguson

Pub. Number AU-A-2007313293

PCT Pub. Number WO2008/048538

Priority 60/852,524 18.10.06 US

Filing date 15 October 2007

Wipo publication date 24 April 2008

International Classifications

C07D 471/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/048538 Priority application(s): WO2008/048538

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007313295-2-hydroxy-2-phenyl/thiophenyl propionamides as androgen receptor modulators

2007313290-Connector for use in single and double breast pumping